Peter J Eggenhuizen

6PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityAutoimmunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 14, 2026
Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease.

Adam R Peterson, Peter J Eggenhuizen, Poh-Yi Gan

|Feb 13, 2026
Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease.

Indiana Zorkau, Peter J Eggenhuizen, Marie Lee

|Mar 28, 2024
The Influence of Cross-Reactive T Cells in COVID-19.

Peter J Eggenhuizen, Joshua D Ooi

|Feb 06, 2024
Smith-specific regulatory T cells halt the progression of lupus nephritis.

Peter J Eggenhuizen, Rachel M Y Cheong, Cecilia Lo

|Sep 26, 2020
Treg Enhancing Therapies to Treat Autoimmune Diseases.

Peter J Eggenhuizen, Boaz H Ng, Joshua D Ooi

|Jul 31, 2019
A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity.

Joshua D Ooi, Jhih-Hang Jiang, Peter J Eggenhuizen

Pageof 1

Frequent Collaborators

3 joint publications

Joshua Ooi

2 joint publications

Khai L Loh

2 joint publications

Rimma Goldberg

1 joint publications

Jhih-Hang Jiang